Company Filing History:
Years Active: 2017-2021
Title: The Innovations of Marc Thomas
Introduction
Marc Thomas is an accomplished inventor based in Vista, California. He has made significant contributions to the field of biotechnology, particularly through his innovative patents. With a total of five patents to his name, Thomas has demonstrated a commitment to advancing medical science and improving treatment methodologies.
Latest Patents
One of Marc Thomas's latest patents is focused on histidyl-tRNA synthetase-Fc conjugates. This invention provides histidyl-tRNA synthetase and Fc region conjugate polypeptides, known as HRS-Fc conjugates. These conjugates, including HRS-Fc fusion polypeptides, are designed for use in various medical applications. The compositions comprising these conjugates offer improved controlled release properties, stability, half-life, and other pharmacokinetic and biological properties compared to unmodified HRS polypeptides. This advancement holds promise for treating and diagnosing a variety of conditions.
Career Highlights
Throughout his career, Marc Thomas has worked with notable companies in the biotechnology sector. He has been associated with Atyr Pharma, Inc. and Pangu Biopharma Limited, where he has contributed to various innovative projects. His work has been instrumental in pushing the boundaries of what is possible in medical treatments.
Collaborations
Marc has collaborated with talented individuals in his field, including Ying Buechler and Kyle P Chiang. These partnerships have fostered a creative environment that encourages innovation and the development of groundbreaking solutions.
Conclusion
Marc Thomas is a prominent figure in the field of biotechnology, with a focus on developing advanced therapeutic solutions. His contributions through patents and collaborations highlight his dedication to improving healthcare outcomes. His work continues to inspire future innovations in the industry.